To investigate the consequences of Usp22 loss in HER2-driven mammary carcinomas, we utilized a transgenic mouse model in which the gene encoding HER2 (Erbb2) was expressed under the mammary-specific MMTV promoter (MMTV-Erbb2). This evidence concerns the gene ERBB2 and breast carcinoma.